Winona, a telehealth platform specialising in perimenopause and menopause care, is positioning itself at the forefront of the fast-growing global “menopause economy,” projected to be worth $600 billion, according to the company.
The company said that its model provides personalised hormone therapy via virtual consultations and home delivery, aiming to remove traditional healthcare barriers for midlife women. Winona claims that this approach addresses a spectrum of needs—ranging from common symptoms such as hot flashes and sleep disturbances to broader concerns including mental health, skin health, weight changes, sexual wellness, and long-term disease prevention.
Expanding femtech investment reflects the growing recognition of this underserved demographic. The company said that it delivers science-backed treatments combined with educational support to empower women during a stage historically marked by neglect and stigma.
Winona claims that by integrating accessible care and educational content, it helps redefine midlife not as decline, but as a dynamic phase with vitality and potential. As the menopause economy accelerates, the company plans to forge partnerships across telehealth, pharmaceutical, and wellness sectors to foster a more cohesive ecosystem for women’s midlife health.
